Experienced in Age-Related Macular Degeneration (ARMD)

Tristan Bourcier

Strasbourg, FR 
Experienced in Age-Related Macular Degeneration (ARMD)
Strasbourg, FR 
OverviewLocationsClinical Research

Overview

Tristan Bourcier practices in Strasbourg, France. Mr. Bourcier is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Interstitial Keratitis, Ocular Toxoplasmosis, Endophthalmitis, Cataract Removal, and Vitrectomy.

His clinical research consists of co-authoring 134 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

Strasbourg, France
Other Locations
Icube CNRS 7357, 10, Avenue Baumann, Illkirch-graffenstaden, 67400, France
Dijon, France
Besancon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective Multicenter, Comparative, Randomized, Single-blind, Non-inferiority Study of Eyestil Protection® Unidose Versus Vismed® Unidose in Patients With Moderate to Severe Dry Eye Syndrome
A Prospective Multicenter, Comparative, Randomized, Single-blind, Non-inferiority Study of Eyestil Protection® Unidose Versus Vismed® Unidose in Patients With Moderate to Severe Dry Eye Syndrome
Enrollment Status: Terminated
Publish Date: May 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Effect of Bevacizumab Subconjunctival Injections on Corneal Newvessels
Effect of Bevacizumab Subconjunctival Injections on Corneal Newvessels
Enrollment Status: Completed
Publish Date: October 24, 2019
Intervention Type: Drug
Study Phase: Phase 3
Robotic Microsurgery of the Ocular surfaceProspective Human Feasibility Study
Robotic Microsurgery of the Ocular surfaceProspective Human Feasibility Study
Enrollment Status: Terminated
Publish Date: August 21, 2019
Intervention Type: Device
Study Phase: Not Applicable
Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.
Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.
Enrollment Status: Completed
Publish Date: December 27, 2018
Intervention Type: Procedure
Study Phase: Phase 3
View 3 Less Clinical Trials

133 Total Publications

Reply to Comment on: Telangiectatic capillaries causing persistent diabetic macula edema successfully treated by photodynamic therapy.
Reply to Comment on: Telangiectatic capillaries causing persistent diabetic macula edema successfully treated by photodynamic therapy.
Journal: Retinal cases & brief reports
Published: December 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bourcier's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile